Zylox-Tonbridge Medical Technology Co., Ltd.
2190.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.37B
Close$
Share Statistics
| Market cap | $6.37 Billion |
|---|---|
| Enterprise Value | $5.97 Billion |
| Dividend Yield | $0.36 (1.76%) |
| Earnings per Share | $0.76 |
| Beta | 0.33 |
| Outstanding Shares | 317,535,000 |
Return
| Return on Equity | 15.30% |
|---|---|
| Return on Assets | 12.20% |
| Return on Invested Capital | 10.95% |
Valuation & Multiples
| P/E Ratio | 18.37 |
|---|---|
| PEG | 36.79 |
| Price to Sales | 3.42 |
| Price to Book Ratio | 2.28 |
| Enterprise Value to Revenue | 2.83 |
| Enterprise Value to EBIT | 16.31 |
| Enterprise Value to Net Income | 13 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 20, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$730.00 M
Average shareholder expectationNext Earnings Call
Expected Date
March 25, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$759.08 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zylox-Tonbridge Medical Technology Co., Ltd.
1,214 employees
CEO: Zhong Zhao Zylox-Tonbridge Medical Technology Co., Ltd. is a global medical device firm specializing in neurovascular and peripheral vascular interventional technologies. Their comprehensive product line for treating ischemic stroke includes the Th...